"Material Time, Material Extent" Proposed Rule Issued By FDA
This article was originally published in The Rose Sheet
Executive Summary
The safety profile of foreign OTC drugs requiring pharmacist intervention will be the deciding factor in an FDA decision to include drug ingredients sold outside the U.S. in an OTC drug monograph.